Tcheng, J. E., Cohen, E. A., Buller, C. E. H., Lincoff, A. M., Joseph, D., Teirstein, P. S., … O’Shea, J. C. (2000). High-dose eptifibatide (Integrilln (R)) in coronary stent implantation: 6 month results of the ESPRIT trial. CIRCULATION, 102(18), 663–663.

Tcheng, J. E., E. A. Cohen, C. E. H. Buller, A. M. Lincoff, D. Joseph, P. S. Teirstein, C. M. Pacchiana, et al. “High-dose eptifibatide (Integrilln (R)) in coronary stent implantation: 6 month results of the ESPRIT trial.” CIRCULATION 102, no. 18 (October 31, 2000): 663–663.

Tcheng JE, Cohen EA, Buller CEH, Lincoff AM, Joseph D, Teirstein PS, et al. High-dose eptifibatide (Integrilln (R)) in coronary stent implantation: 6 month results of the ESPRIT trial. CIRCULATION. 2000 Oct 31;102(18):663–663.

Tcheng, J. E., et al. “High-dose eptifibatide (Integrilln (R)) in coronary stent implantation: 6 month results of the ESPRIT trial.” CIRCULATION, vol. 102, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2000, pp. 663–663.

Tcheng JE, Cohen EA, Buller CEH, Lincoff AM, Joseph D, Teirstein PS, Pacchiana CM, Madan M, Cantor WJ, Lorenz TJ, Kitt MM, O’Shea JC. High-dose eptifibatide (Integrilln (R)) in coronary stent implantation: 6 month results of the ESPRIT trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000 Oct 31;102(18):663–663.